Elevance Health (ELV) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $6.99
- Estimate
- $4.69
- Surprise
- +48.9%
- Revenue (period 2026-09-30)
- $51.43B
- Score today
- 5.1/10
Revenue source: xbrl.
How the report landed
Elevance Health (ELV) beat the $4.69 estimate with adjusted EPS of $6.99 — a large 48.9% upside surprise.
Coverage in the report window
- RBC Raises Price Target on Elevance Health to $455 From $424 — fiscal.ai, 2026-10-22
- Baird Maintains Neutral on Elevance Health, Raises Price Target to $406 — benzinga, 2026-10-22
- Jefferies Adjusts Price Target on Elevance Health to $510 From $450 — fiscal.ai, 2026-10-22
Where TrendMatrix's rating stands now
TrendMatrix currently rates ELV Sell at 5.1/10; no pre/post engine snapshot brackets this report.
4 of the last 4 quarters beat the estimate; this quarter's +48.9% surprise compares with a +23.2% four-quarter average.
What argues against it
- Target reached (-5.5% upside)
- Quality below floor (3.9 < 4.0)
- Negative risk/reward — downside exceeds upside
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $434.13
- Stop
- $411.29
The stock trades at 18.4× trailing but 14.6× forward earnings — consensus estimates already build in a substantial earnings recovery.
Risk check: RSI 87 — a level conventionally read as overbought; gains at these levels often lean on momentum; trading volume is running 1.9× its average — elevated turnover around the report window.
Model outputs from TrendMatrix’s engine as of 2026-10-22 — shown for context, not personalized investment advice.
ELV at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Healthcare Plans
- Market cap
- $94.15B
- P/E (fwd)
- 14.6
- P/E (ttm)
- 18.4
- 52-week range
- $274.84–$450.69
- Off 52-week high
- 3.7%
- RSI (14)
- 87
- Volume vs avg
- 1.88×
- Score today
- 5.1/10